ESHIMT courses and endorsed events
Here you can find an overview of courses and events that are organised, co-organised or endorsed by ESHIMT
Besides our own events, we are very selective with our recommendations and therefore advise you to have a look at them in detail.
1st PET/MRI Symposium
Essen – Tübingen
“PET/MR in oncology – present role and future directions”
3rd & 4th May 2019
The first joint Essen – Tübingen PET/MRI Symposium intends to provide a forum to clinical PET/MR users all around Europe and like to emphasize interactive, moderated dialogues on recent to emerging applications, advanced image processing and image analysis as well as its significance in modern personalized medicine.
We have chosen the parent topic “PET/MRI in oncology – present and future directions” and hope to excite lively discussions in a series of sessions:
- Imaging in oncology: The battle of modalities
- Complex imaging protocols & advanced image analysis
- How do we do it – and what do we do? (Experiences of different PET/MR centers)
- PET/MR in Oncology (prostate, female, pediatric & neuro-oncological imaging)
EUROPEAN CANCER CARE: ACROSS BORDERS
12-14 September 2019
The ECCO 2019 European Cancer Summit on 12-14 September 2019 in Brussels, Belgium will bring together worldwide leaders from cancer care, research, patient advocacy and public-private sectors in a unique multi-stakeholder forum. The theme of the second edition of the ECCO Summit is: “European Cancer Care: Across Borders”.
The ECCO 2019 European Cancer Summit will:
- Debate leading-edge ideas in achieving improvement in cancer care
- Determine consensus resolutions for improving health systems
- Decide on an action plan for the way forward to ensure ideas translate into policies that will impact daily clinical practice
Read more here: www.eccosummit.eu
ESHI Course 2017: Hybrid Imaging in Oncology
December 14-15, 2017 | Vienna, Austria
Enjoy some impressions from the 2017 course in Vienna. More than 150 participants from 42 countries gathered in Vienna to learn more about the indications, limitations and comparative merits of each part in hybrid medical imaging in a wide range of oncologic conditions.